These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7960461)

  • 21. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances.
    Serre F; Fatseas M; Denis C; Swendsen J; Auriacombe M
    Addict Behav; 2018 Aug; 83():123-129. PubMed ID: 29428330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
    Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N;
    BMC Psychiatry; 2018 May; 18(1):140. PubMed ID: 29776349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analgesic nitrous oxide for addictive withdrawal states.
    Gillman MA
    S Afr Med J; 1989 Feb; 75(3):100-1. PubMed ID: 2919321
    [No Abstract]   [Full Text] [Related]  

  • 24. Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from Ecological Momentary Assessment.
    Buckner JD; Zvolensky MJ; Crosby RD; Wonderlich SA; Ecker AH; Richter A
    Drug Alcohol Depend; 2015 Feb; 147():20-5. PubMed ID: 25578250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid effects of analgesic (subanesthetic) nitrous oxide on the alcohol withdrawal state.
    Gillman MA; Lichtigfeld FJ
    Ann N Y Acad Sci; 1991; 625():784-5. PubMed ID: 2058933
    [No Abstract]   [Full Text] [Related]  

  • 27. Placebo and analgesic nitrous oxide for treatment of the alcohol withdrawal state.
    Gillman MA; Lichtigfeld FJ
    Br J Psychiatry; 1991 Nov; 159():672-5. PubMed ID: 1756344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychotropic analgesic nitrous oxide for acute cocaine withdrawal in man.
    Gillman MA; Lichtigfeld FJ; Harker N
    Int J Neurosci; 2006 Jul; 116(7):847-57. PubMed ID: 16861150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary effects of progressive muscle relaxation on cigarette craving and withdrawal symptoms in experienced smokers in acute cigarette abstinence: a randomized controlled trial.
    Limsanon T; Kalayasiri R
    Behav Ther; 2015 Mar; 46(2):166-76. PubMed ID: 25645166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence.
    Boden MT; Babson KA; Vujanovic AA; Short NA; Bonn-Miller MO
    Am J Addict; 2013; 22(3):277-84. PubMed ID: 23617872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bupropion for the treatment of nicotine withdrawal and craving.
    Mooney ME; Sofuoglu M
    Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial.
    Alho H; Methuen T; Paloheimo M; Strid N; Seppä K; Tiainen J; Salaspuro M; Roine R
    Alcohol Clin Exp Res; 2002 Dec; 26(12):1816-22. PubMed ID: 12500105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic nitrous oxide in alcohol withdrawal: the role of melatonin.
    Sandyk R
    Int J Neurosci; 1991; 56(1-4):201-5, 207-8. PubMed ID: 1938137
    [No Abstract]   [Full Text] [Related]  

  • 34. Nitrous oxide has no effect in the treatment of alcohol withdrawal syndrome: a double-blind placebo-controlled randomized trial.
    Alho H; Methuen T; Paloheimo M; Seppä K; Strid N; Apter-Kaseva N; Tiainen J; Salaspuro M; Roine R
    J Clin Psychopharmacol; 2003 Apr; 23(2):211-4. PubMed ID: 12640227
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cannabis: Use and dependence].
    Dervaux A; Laqueille X
    Presse Med; 2012 Dec; 41(12 Pt 1):1233-40. PubMed ID: 23040955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users.
    Kaag AM; Schulte MHJ; Jansen JM; van Wingen G; Homberg J; van den Brink W; Wiers RW; Schmaal L; Goudriaan AE; Reneman L
    Drug Alcohol Depend; 2018 Jun; 187():186-194. PubMed ID: 29679913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence.
    Viola TW; Tractenberg SG; Wearick-Silva LE; Rosa CS; Pezzi JC; Grassi-Oliveira R
    Drug Alcohol Depend; 2014 Nov; 144():153-9. PubMed ID: 25262527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and Preliminary Effectiveness of Varenicline for Treating Co-Occurring Cannabis and Tobacco Use.
    Adams TR; Arnsten JH; Ning Y; Nahvi S
    J Psychoactive Drugs; 2018; 50(1):12-18. PubMed ID: 28952897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitrous oxide for alcohol withdrawal.
    Daynes G
    S Afr Med J; 1994 Oct; 84(10):708. PubMed ID: 7839273
    [No Abstract]   [Full Text] [Related]  

  • 40. Craving in patients with schizophrenia and cannabis use disorders.
    Schnell T; Becker T; Thiel MC; Gouzoulis-Mayfrank E
    Can J Psychiatry; 2013 Nov; 58(11):646-9. PubMed ID: 24246436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.